Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (9967)	5/14/1999 2:26:00 PM
From: xomadog2	Read Replies (2) \| Respond to of 17367

George- As much as anyone,I would love to know more about the details of what goes on during a trial. However,Xoma has a track record with the FDA, having to do with E-5 that was combative,to say the least! In light of that,I am strongly in favor of the company deciding to be most conservative in the news it releases about its trials or products. Yes,it would be wonderful to have known what the specific mortality event target was and what progress was being made toward that number,but, if in fact the DSMB was specific about not letting this info out to the public or not,the company chose to be silent about all this and if you are a long term shareholder you have to respect the choice they have made. You might not agree with the choice the company made. I do! In fact, I believe,in the interest of approval of this compound,that the company should say as little as possible about the appoval process before or after the drug is approved.

To: aknahow who wrote (9967)	5/14/1999 8:09:00 PM
From: William L. Molair II	Read Replies (2) \| Respond to of 17367

George, I left several questions for Ellen on Thursday. She returned my call today and said that she was very busy yesterday with the CIBC folks and working on the mengio announcement for today (why she didn't return my call until today). She said quarterly numbers will be published on Monday. I called back and left a couple-o-questions (can she provide more info on the CIBC recommendation, how long until the data is unblinded - 30 or 90 days, and would Xoma hold the data results until a medical conference - man I hope they are not waiting until November!). Will post the answers when I get them.